Literature DB >> 36268064

Spatial heterogeneity and organization of tumor mutation burden with immune infiltrates within tumors based on whole slide images correlated with patient survival in bladder cancer.

Hongming Xu1,2, Jean René Clemenceau3, Sunho Park3, Jinhwan Choi3, Sung Hak Lee4, Tae Hyun Hwang3.   

Abstract

Background: High tumor mutation burden (TMB-H) could result in an increased number of neoepitopes from somatic mutations expressed by a patient's own tumor cell which can be recognized and targeted by neighboring tumor-infiltrating lymphocytes (TILs). Deeper understanding of spatial heterogeneity and organization of tumor cells and their neighboring immune infiltrates within tumors could provide new insights into tumor progression and treatment response.
Methods: Here we first developed computational approaches using whole slide images (WSIs) to predict bladder cancer patients' TMB status and TILs across tumor regions, and then investigate spatial heterogeneity and organization of regions harboring TMB-H tumor cells and TILs within tumors, as well as their prognostic utility.
Results: In experiments using WSIs from The Cancer Genome Atlas (TCGA) bladder cancer (BLCA), our findings show that computational pathology can reliably predict patient-level TMB status and delineate spatial TMB heterogeneity and co-organization with TILs. TMB-H patients with low spatial heterogeneity enriched with high TILs show improved overall survival. Conclusions: Computational approaches using WSIs have the potential to provide rapid and cost-effective TMB testing and TILs detection. Survival analysis illuminates potential clinical utility of spatial heterogeneity and co-organization of TMB and TILs as a prognostic biomarker in BLCA which warrants further validation in future studies.
© 2022 The Authors.

Entities:  

Keywords:  BLCA, Urothelial Bladder Carcinoma; Bladder cancer; Computational pathology; Spatial Heterogeneity; Survival prognosis; TCGA, The Cancer Genome Atlas Project; TIL, Tumor-Infiltrating Lymphocyte; TMB, Tumor Mutation Burden; Tumor Immune Microenvironment; Tumor mutation burden prediction; WSI, Whole Slide Image

Year:  2022        PMID: 36268064      PMCID: PMC9577053          DOI: 10.1016/j.jpi.2022.100105

Source DB:  PubMed          Journal:  J Pathol Inform


  44 in total

Review 1.  Understanding the tumor immune microenvironment (TIME) for effective therapy.

Authors:  Mikhail Binnewies; Edward W Roberts; Kelly Kersten; Vincent Chan; Douglas F Fearon; Miriam Merad; Lisa M Coussens; Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Catherine C Hedrick; Robert H Vonderheide; Mikael J Pittet; Rakesh K Jain; Weiping Zou; T Kevin Howcroft; Elisa C Woodhouse; Robert A Weinberg; Matthew F Krummel
Journal:  Nat Med       Date:  2018-04-23       Impact factor: 53.440

2.  Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer.

Authors:  Scarlet Brockmoeller; Amelie Echle; Narmin Ghaffari Laleh; Susanne Eiholm; Marie Louise Malmstrøm; Tine Plato Kuhlmann; Katarina Levic; Heike Irmgard Grabsch; Nicholas P West; Oliver Lester Saldanha; Katerina Kouvidi; Aurora Bono; Lara R Heij; Titus J Brinker; Ismayil Gögenür; Philip Quirke; Jakob Nikolas Kather
Journal:  J Pathol       Date:  2021-12-28       Impact factor: 7.996

Review 3.  Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.

Authors:  Andriy Marusyk; Michalina Janiszewska; Kornelia Polyak
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

Review 4.  The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies.

Authors:  Eric A Smith; H Courtney Hodges
Journal:  Trends Cancer       Date:  2019-06-18

5.  Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.

Authors:  Kroopa Joshi; Marc Robert de Massy; Mazlina Ismail; James L Reading; Imran Uddin; Annemarie Woolston; Emine Hatipoglu; Theres Oakes; Rachel Rosenthal; Thomas Peacock; Tahel Ronel; Mahdad Noursadeghi; Virginia Turati; Andrew J S Furness; Andrew Georgiou; Yien Ning Sophia Wong; Assma Ben Aissa; Mariana Werner Sunderland; Mariam Jamal-Hanjani; Selvaraju Veeriah; Nicolai J Birkbak; Gareth A Wilson; Crispin T Hiley; Ehsan Ghorani; José Afonso Guerra-Assunção; Javier Herrero; Tariq Enver; Sine R Hadrup; Allan Hackshaw; Karl S Peggs; Nicholas McGranahan; Charles Swanton; Sergio A Quezada; Benny Chain
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

6.  Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies.

Authors:  Andrea Necchi; Daniele Raggi; Andrea Gallina; Russell Madison; Maurizio Colecchia; Roberta Lucianò; Rodolfo Montironi; Patrizia Giannatempo; Elena Farè; Filippo Pederzoli; Marco Bandini; Marco Bianchi; Renzo Colombo; Giorgio Gandaglia; Nicola Fossati; Laura Marandino; Umberto Capitanio; Federico Dehò; Siraj M Ali; Jon H Chung; Jeffrey S Ross; Andrea Salonia; Alberto Briganti; Francesco Montorsi
Journal:  Eur Urol       Date:  2019-11-08       Impact factor: 20.096

7.  Pan-cancer image-based detection of clinically actionable genetic alterations.

Authors:  Alexander T Pearson; Tom Luedde; Jakob Nikolas Kather; Lara R Heij; Heike I Grabsch; Chiara Loeffler; Amelie Echle; Hannah Sophie Muti; Jeremias Krause; Jan M Niehues; Kai A J Sommer; Peter Bankhead; Loes F S Kooreman; Jefree J Schulte; Nicole A Cipriani; Roman D Buelow; Peter Boor; Nadi-Na Ortiz-Brüchle; Andrew M Hanby; Valerie Speirs; Sara Kochanny; Akash Patnaik; Andrew Srisuwananukorn; Hermann Brenner; Michael Hoffmeister; Piet A van den Brandt; Dirk Jäger; Christian Trautwein
Journal:  Nat Cancer       Date:  2020-07-27

8.  Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?

Authors:  Chiara Maria Lavinia Loeffler; Nadina Ortiz Bruechle; Max Jung; Lancelot Seillier; Michael Rose; Narmin Ghaffari Laleh; Ruth Knuechel; Titus J Brinker; Christian Trautwein; Nadine T Gaisa; Jakob N Kather
Journal:  Eur Urol Focus       Date:  2021-04-22

9.  The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer.

Authors:  Yaxiong Zhang; Lianpeng Chang; Yunpeng Yang; Wenfeng Fang; Yanfang Guan; Aiwei Wu; Shaodong Hong; Huaqiang Zhou; Gang Chen; Xi Chen; Shen Zhao; Qiufan Zheng; Hui Pan; Lanjun Zhang; Hao Long; Haoxian Yang; Xin Wang; Zhesheng Wen; Junye Wang; Hong Yang; Xuefeng Xia; Yuanyuan Zhao; Xue Hou; Yuxiang Ma; Ting Zhou; Zhonghan Zhang; Jianhua Zhan; Yan Huang; Hongyun Zhao; Ningning Zhou; Xin Yi; Li Zhang
Journal:  J Immunother Cancer       Date:  2019-04-03       Impact factor: 13.751

10.  Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.

Authors:  Xin Hu; Junya Fujimoto; Lisha Ying; Ignacio I Wistuba; Waun Ki Hong; P Andrew Futreal; Dan Su; Jianjun Zhang; Junya Fukuoka; Kazuto Ashizawa; Wenyong Sun; Alexandre Reuben; Chi-Wan Chow; Nicholas McGranahan; Runzhe Chen; Jinlin Hu; Myrna C Godoy; Kazuhiro Tabata; Kishio Kuroda; Lei Shi; Jun Li; Carmen Behrens; Edwin Roger Parra; Latasha D Little; Curtis Gumbs; Xizeng Mao; Xingzhi Song; Samantha Tippen; Rebecca L Thornton; Humam Kadara; Paul Scheet; Emily Roarty; Edwin Justin Ostrin; Xu Wang; Brett W Carter; Mara B Antonoff; Jianhua Zhang; Ara A Vaporciyan; Harvey Pass; Stephen G Swisher; John V Heymach; J Jack Lee
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.